Stay updated on OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial
Sign up to get notified when there's something new on the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page.

Latest updates to the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the temporary government funding notice was removed; these updates are minor and do not affect study content or how users interact with the page.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center operating status was added, along with page revision dates indicating updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedAdditions: glossary toggle, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; Deletions: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 removed, and this is a minor backend update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a new Locations section with study sites in California, Ohio, and Pennsylvania. The page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.4%

- Check85 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of v3.3.1. This is a minor UI/version update and does not affect the study details.SummaryDifference0.1%

Stay in the know with updates to OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page.